Shares of Celestica plunged 14.7% to CA$433.71 after the data-center hardware maker sold nearly 9.7 million new shares at US$310 apiece — a steep discount to the prior close — raising US$3 billion to bankroll its AI infrastructure ambitions. The company framed the raise as a response to "unprecedented multi-year demand from its customer base," but the market's verdict was swift and punishing.
A Deep Discount That Spooked the Market
Celestica priced the new shares at US$310 each, below Wednesday's closing price of US$362.76. That roughly 14% haircut to the last trade signaled urgency rather than strength, prompting existing holders to sell down toward the offer price. The sizeable equity raise comes after a strong run in Celestica's share price, with the discounted issue prompting investors to lock in gains.
Existing Shareholders Now Own a Smaller Slice of the Pie
The equity raise dilutes shares by roughly 8.4%, pressuring forward earnings per share and likely prompting negative earnings revisions in the coming months.
Before the deal, Celestica had about 114.98 million shares outstanding. Underwriters also hold an option to purchase an additional 1,451,612 shares within 30 days, which could widen the dilution further if exercised.
The Business Is Booming — On Paper
For the last twelve months ended June 30, 2026, revenue was US$15.6 billion, up approximately 47% from the prior period.
In Q2, the company beat analyst estimates, posting adjusted EPS of US$2.54 versus the Street's US$2.30.
Celestica's return on invested capital has run between 30% and 50%, showing management has been efficient so far — the question is whether US$3 billion in fresh capital can earn anywhere near that rate.
Growth Catalysts Are Real, But Patience Is Required
New AI infrastructure projects with Broadcom and AMD remain strong catalysts, but top-line benefits will materialize gradually.
Proceeds will fund working capital and capital expenditures — vague language that leaves investors guessing about specific return timelines. The most recent analyst consensus on CLS carries a Buy rating with a CA$485 price target, but at least one analyst has already downgraded the stock to Hold, citing near-term dilution and valuation premium risk.
The core tension is clear: Celestica is riding a genuine AI-driven demand wave, but asking shareholders to absorb an 8.4% ownership haircut on a vague capex promise is a leap of faith the market isn't rewarding today.